Lattice Biologics Ltd
OTC:LBLTF
Lattice Biologics Ltd
OTC:LBLTF
Price:
0.0001
USD
Market Closed
Market Cap:
$4.1m
Balance Sheet
Balance Sheet Decomposition
Lattice Biologics Ltd
Lattice Biologics Ltd
Balance Sheet Decomposition is not available for
Lattice Biologics Ltd
Lattice Biologics Ltd
Balance Sheet
Lattice Biologics Ltd
Lattice Biologics Ltd
Currency: USD
| Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
1
|
1
|
|
| PP&E Net |
32
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
2
|
|
| PP&E Gross |
32
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
53
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Assets |
33
N/A
|
1
-98%
|
0
-69%
|
0
-67%
|
0
-85%
|
4
+39 760%
|
3
-6%
|
3
-11%
|
2
-26%
|
3
+33%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
2
|
2
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
6
|
7
|
7
|
8
|
8
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| Deferred Income Tax |
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
4
N/A
|
0
-91%
|
0
-27%
|
0
+75%
|
0
+2%
|
8
+1 861%
|
8
-8%
|
8
+9%
|
9
+2%
|
9
+10%
|
|
| Equity | |||||||||||
| Common Stock |
48
|
47
|
48
|
45
|
36
|
5
|
10
|
10
|
10
|
11
|
|
| Retained Earnings |
26
|
46
|
48
|
45
|
37
|
10
|
14
|
15
|
16
|
17
|
|
| Additional Paid In Capital |
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
29
N/A
|
0
-99%
|
0
N/A
|
0
-500%
|
0
-16%
|
5
-1 024%
|
4
+9%
|
5
-25%
|
6
-19%
|
6
-1%
|
|
| Total Liabilities & Equity |
33
N/A
|
1
-98%
|
0
-69%
|
0
-67%
|
0
-85%
|
4
+39 760%
|
3
-6%
|
3
-11%
|
2
-26%
|
3
+33%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
6
|
6
|
6
|
6
|
6
|
63
|
93
|
93
|
93
|
128
|
|
Switch to:
Switch to:
See Also
Discover More
